Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 12 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: A4H9D7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 111 | 115 | PF00656 | 0.528 |
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.717 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.614 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.649 |
CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.443 |
CLV_NRD_NRD_1 | 227 | 229 | PF00675 | 0.456 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.484 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.614 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.648 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.674 |
CLV_PCSK_SKI1_1 | 202 | 206 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.670 |
DEG_APCC_DBOX_1 | 201 | 209 | PF00400 | 0.381 |
DEG_MDM2_SWIB_1 | 190 | 197 | PF02201 | 0.365 |
DOC_MAPK_MEF2A_6 | 202 | 209 | PF00069 | 0.358 |
DOC_MAPK_NFAT4_5 | 202 | 210 | PF00069 | 0.358 |
DOC_PP1_RVXF_1 | 20 | 26 | PF00149 | 0.462 |
DOC_PP1_RVXF_1 | 200 | 207 | PF00149 | 0.399 |
DOC_PP1_RVXF_1 | 3 | 9 | PF00149 | 0.459 |
DOC_PP2B_LxvP_1 | 208 | 211 | PF13499 | 0.481 |
DOC_PP4_FxxP_1 | 25 | 28 | PF00568 | 0.355 |
DOC_SPAK_OSR1_1 | 189 | 193 | PF12202 | 0.381 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.299 |
DOC_USP7_UBL2_3 | 215 | 219 | PF12436 | 0.693 |
DOC_USP7_UBL2_3 | 62 | 66 | PF12436 | 0.275 |
LIG_14-3-3_CanoR_1 | 135 | 141 | PF00244 | 0.449 |
LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 43 | 51 | PF00244 | 0.445 |
LIG_Actin_WH2_1 | 189 | 204 | PF00022 | 0.447 |
LIG_Actin_WH2_2 | 175 | 191 | PF00022 | 0.421 |
LIG_AP2alpha_2 | 155 | 157 | PF02296 | 0.492 |
LIG_BIR_III_4 | 79 | 83 | PF00653 | 0.284 |
LIG_EH_1 | 174 | 178 | PF12763 | 0.495 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.540 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.456 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.710 |
LIG_IBAR_NPY_1 | 49 | 51 | PF08397 | 0.272 |
LIG_LIR_Apic_2 | 24 | 28 | PF02991 | 0.356 |
LIG_LIR_Gen_1 | 139 | 147 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 93 | 102 | PF02991 | 0.293 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 85 | 91 | PF02991 | 0.279 |
LIG_LIR_Nem_3 | 93 | 98 | PF02991 | 0.272 |
LIG_MAD2 | 70 | 78 | PF02301 | 0.284 |
LIG_PDZ_Class_2 | 240 | 245 | PF00595 | 0.656 |
LIG_Pex14_1 | 194 | 198 | PF04695 | 0.309 |
LIG_Pex14_2 | 190 | 194 | PF04695 | 0.370 |
LIG_Pex14_2 | 209 | 213 | PF04695 | 0.578 |
LIG_SH2_CRK | 51 | 55 | PF00017 | 0.276 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.276 |
LIG_SH2_STAP1 | 140 | 144 | PF00017 | 0.429 |
LIG_SH2_STAP1 | 51 | 55 | PF00017 | 0.191 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.503 |
LIG_SH3_1 | 229 | 235 | PF00018 | 0.670 |
LIG_SH3_1 | 75 | 81 | PF00018 | 0.284 |
LIG_SH3_3 | 214 | 220 | PF00018 | 0.600 |
LIG_SH3_3 | 227 | 233 | PF00018 | 0.703 |
LIG_SH3_3 | 75 | 81 | PF00018 | 0.284 |
LIG_SH3_4 | 215 | 222 | PF00018 | 0.709 |
LIG_SUMO_SIM_par_1 | 52 | 58 | PF11976 | 0.191 |
LIG_TRFH_1 | 206 | 210 | PF08558 | 0.353 |
LIG_UBA3_1 | 205 | 212 | PF00899 | 0.581 |
LIG_WW_3 | 215 | 219 | PF00397 | 0.705 |
LIG_WW_3 | 220 | 224 | PF00397 | 0.750 |
MOD_CK1_1 | 136 | 142 | PF00069 | 0.455 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.496 |
MOD_Cter_Amidation | 226 | 229 | PF01082 | 0.529 |
MOD_GlcNHglycan | 109 | 113 | PF01048 | 0.690 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.734 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.718 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.613 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.544 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.425 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.471 |
MOD_PIKK_1 | 37 | 43 | PF00454 | 0.531 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.456 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.434 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.454 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.357 |
MOD_SUMO_for_1 | 211 | 214 | PF00179 | 0.639 |
MOD_SUMO_rev_2 | 58 | 68 | PF00179 | 0.299 |
MOD_SUMO_rev_2 | 79 | 88 | PF00179 | 0.290 |
TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.434 |
TRG_ENDOCYTIC_2 | 144 | 147 | PF00928 | 0.415 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.275 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.276 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.276 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.424 |
TRG_ER_diArg_1 | 172 | 174 | PF00400 | 0.471 |
TRG_ER_diArg_1 | 225 | 228 | PF00400 | 0.742 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PA62 | Leptomonas seymouri | 70% | 100% |
A0A0S4IP06 | Bodo saltans | 31% | 100% |
A0A1X0NIB0 | Trypanosomatidae | 29% | 100% |
A0A1X0P719 | Trypanosomatidae | 61% | 100% |
A0A3Q8IAY4 | Leishmania donovani | 85% | 100% |
A0A3R7M6A3 | Trypanosoma rangeli | 60% | 100% |
A4HJV4 | Leishmania braziliensis | 28% | 100% |
A4HXQ8 | Leishmania infantum | 85% | 100% |
B6DTF2 | Bodo saltans | 51% | 100% |
D0A039 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 100% |
E9ARH0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4QE09 | Leishmania major | 85% | 100% |